Calcium Channel Blockers and Renal Disease. (Record no. 59959)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05645nam a22004813i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3018941 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124109.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2009 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781612098678 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781607419754 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3018941 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3018941 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10662747 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)847090008 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC903 -- .C25 2009eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.6/1061 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Robles, Nicolás Roberto. |
| 245 10 - TITLE STATEMENT | |
| Title | Calcium Channel Blockers and Renal Disease. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2009. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2009. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (195 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Cerebrovascular Research and Disorders |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- CALCIUM CHANNEL BLOCKERSAND RENAL DISEASE -- CALCIUM CHANNEL BLOCKERS AND RENAL DISEASE -- Contents -- Preface -- List of Authors -- Pharmacology of CalciumAntagonists -- Mechanisms of Action -- Differences among Calcium-Antagonists -- Clinical Pharmacology -- Pharmacokinetics -- Pharmacodynamics -- Tolerance -- Sympathetic Activation -- Ankle edema -- Other Untoward Effects -- Therapeutic Uses -- Hypertension -- Angina Pectoris -- Supraventricular Arrhythmias -- Subarachnoid Hemorrhage -- Myocardial Infarction -- Risk of Cancer -- Drug Interactions -- Special Considerations -- Older Patients -- Metabolic Syndrome -- Patients with Congestive Heart Failure -- Overdose of CCBs -- References -- Calcium Antagonists and SystemicHypertension -- Abstract -- Calcium Channel Blockers:The Findings of Clinical Trials -- Calcium Channel Blockers and Target OrganDisease -- 1. Calcium Channel Blockers and Arteriosclerosis -- 2. Use of Calcium Channel Antagonists in Coronary Disease(CHD) -- 3. Effects on Cerebrovascular Disease: Clinical Trials -- 4. Meta-Analysis on Cerebrovascular Outcomes -- Conclusions -- References -- Effects of Calcium Antagonists inRenal Hemodynamics -- Abstract -- 1. Ca2+ Channels and Vasoconstriction -- 1.1. Diversity of Ca2+ Channels -- 1.2. The Traditional Vision: The Role of L-Type Ca2+ Channels -- 1.3. The Emerging Evidences for Other Types of Ca2+ Channels -- 2. The Use of CCBs for BP Control inHypertension -- 2.1. The Principle of Ca2+ Antagonism -- 2.2. The Mechanism of "Ca2+ Antagonism" in Hypertension -- 3. Effects of CCBs on Microcirculation andRenal Hemodynamics -- 3.1. CCBs and Renal Protection -- 3.2. Mechanisms for Beneficial Renal Effects of New CCBs -- 3.2.1. DHP-Insensitive Ca2+ Channels in the Microcirculation andKidneys -- 3.2.2. DHP-Insensitive Ca2+ Channels in the Sympathetic Nerves. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3.2.3. New DHPs Cause New Effects on Renal Function -- 3.2.4. Limitations and Pertaining Questions -- Conclusion - Prospects -- References -- The Non-Hemodynamic Effects ofCalcium Channel Blockers on theKidney -- 1. Introduction -- 2. Antioxidant Effects -- 2.1. End-Stage Renal Disease -- 2.2. Diabetes -- 2.3. Effects of Associations -- 3. Effect on the Proliferation of MesangialCells -- 4. Effect on Fibrosis and Apoptosis -- 5. Other Effects -- Summary -- References -- Renoprotective Effect of CalciumAntagonists in SystemicHypertension -- Introduction -- Overview of Relevant Trials Regarding CCBsand Renal Protection in HypertensivePatients -- CCBs and Renal Protection in the Presenceof Preserved Renal Function -- Blood Pressure Control andNephroprotection in Patients withEstablished Chronic Kidney Disease -- Conclusions -- References -- Calcium Antagonists and RenalDisease -- Introduction -- Effects Calcium Channel Blockers on RenalHemodynamics -- Renoprotective Effect of CalciumAntagonists in Animals -- Effects on the Progression of Renal Injuryin Humans -- Calcium Antagonists versus Renin-Angiotensin Axis Blocking Drugs -- Calcium Antagonists versus Diuretics -- Comparison between Calcium-Antagonists -- New Calcium Antagonists -- Conclusion -- References -- Renal Ischaemia and CalciumChannel Blockers (CCBs) -- Introduction -- Chronic Renal Ischaemia -- Definition -- Pathogenic Mechanisms -- Epidemiology -- Morphology -- Clinical Presentation -- Calcium Channel Blockers and RID -- Contrast-Induced Nephropathy AND CCBs -- Risk Factors OF CIN -- Prevention of Radiocontrast Nephropathy -- References -- Calcium Antagonist after KidneyTransplantation -- Drug Treatment in Post-TransplantationArterial Hypertension -- References -- Non Dihydropyridinic CalciumAntagonists and Renal Disease. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Nondihydropiridine Calcium ChannelBlockers vs Other Antihypertensive Agents -- Combination Therapy -- Conclusions -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kidneys -- Diseases -- Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium -- Antagonists. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Robles, Nicolás Roberto |
| Title | Calcium Channel Blockers and Renal Disease |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2009 |
| International Standard Book Number | 9781607419754 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Cerebrovascular Research and Disorders |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018941">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018941</a> |
| Public note | Click to View |
No items available.